Cabergoline
RxNorm 47579
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 47579 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cabergoline.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Cabergoline
(Atom ID: 510221)
PTPrescribable
Designated preferred name (PT):
Cabergoline
(Atom ID: 510226)
FNPrescribable
Full form of descriptor (FN):
Cabergoline (substance)
(Atom ID: 510235)
PTPrescribable
Designated preferred name (PT):
Cabergoline-containing product
(Atom ID: 10798590)
FNPrescribable
Full form of descriptor (FN):
Product containing cabergoline (medicinal product)
(Atom ID: 9254552)
Patient Education
Cabergoline
Cabergoline is used to treat hyperprolactinemia (high levels of prolactin, a natural substance that helps breast-feeding women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding or men). Cabergoline is in a class of medications called dopamine receptor agonists. It works by decreasing the amount of prolactin in the body.
[Learn More]
* Please review the disclaimer below.